Potency Versus Purity in Pharmaceutical and Drug Product Analysis - Tech Information
March 15, 2013
/

Date: 15-MARCH2013   Last Updated: 5-SEPTEMBER-2026

Introduction

Potency and purity are two of the most important quality attributes evaluated during pharmaceutical development, manufacturing, quality control, and stability testing. Although these terms are sometimes used interchangeably, they represent different measurements and answer different analytical questions.

Understanding the distinction between potency and purity is essential when interpreting assay results, impurity profiles, and regulatory specifications for drug substances and drug products.


What Is Potency?

Potency is a measure of the biological, pharmacological, or therapeutic activity of a drug.  In simple terms, potency reflects the amount of a substance required to produce a defined effect.

A highly potent compound produces the desired effect at a lower quantity, while a less potent compound requires a larger amount to achieve the same effect.

Potency assessments may be based on:

  • Biological activity
  • Pharmacological response
  • Chemical assay results
  • Drug strength specifications
  • Therapeutic performance

Depending on the product and regulatory requirements, potency may be determined through chemical, biochemical, or biological testing methods.


What Is Purity?

Purity is a measure of how much of the desired active pharmaceutical ingredient (API) is present relative to other substances.

These other substances may include:

  • Related compounds
  • Process impurities
  • Degradation products
  • Residual solvents
  • By-products
  • Contaminants

A purity determination evaluates the composition of the material and helps establish whether unacceptable levels of impurities are present.  Chromatographic techniques such as HPLC are commonly used for impurity profiling and purity assessments.


Why Potency and Purity Are Not the Same

A drug product can be highly pure but not necessarily highly potent.  Likewise, a drug product can demonstrate potency while still containing unacceptable levels of impurities.

For example:

  • A material may contain a high percentage of the desired API and therefore exhibit excellent purity.
  • However, degradation of the active compound may reduce its biological effectiveness, resulting in lower potency.

Conversely:

  • A compound may maintain biological activity and potency.
  • Yet impurities or related substances may be present at levels that fail purity specifications.

Because they measure different characteristics, both parameters are often evaluated independently during pharmaceutical testing.


Role of HPLC in Potency and Purity Testing

HPLC plays an important role in evaluating both quality attributes.

Applications include:

Potency Testing

  • Assay determination
  • Drug strength verification
  • Quantitative analysis of API concentration

Purity Testing

  • Impurity profiling
  • Related substance analysis
  • Stability-indicating methods
  • Degradation product monitoring
  • Residual solvent evaluation (with complementary techniques when appropriate)

The same chromatographic method may sometimes provide information relevant to both potency and purity evaluations.


Pharmaceutical Quality and Regulatory Expectations

Regulatory agencies and industry guidelines typically require evaluation of both potency and purity throughout a product's lifecycle.

These assessments help ensure:

  • Product consistency
  • Patient safety
  • Therapeutic effectiveness
  • Manufacturing control
  • Regulatory compliance

Acceptance criteria are generally established during method development, validation, and product qualification studies.


Reference Guidance

Additional information regarding potency, purity, assay methods, impurities, and related substances can be found in relevant ICH guidelines and regulatory documents applicable to pharmaceutical analysis and product quality.


Conclusion

Potency and purity are separate but equally important measures of pharmaceutical quality. Potency reflects the biological or therapeutic effectiveness of a drug, while purity measures the amount of the desired active ingredient relative to impurities, degradation products, and other related substances. Together, these parameters provide a more complete assessment of drug quality, safety, and performance.


Related Articles

  1. Difference between assay and purity regarding pharmaceutical analysis - Primer
  2. Permitted Method Adjustments in USP Chromatographic Procedures - Tech Information

© Copyright 2026. MICROSOLV. All Rights Reserved. Website & Hosting by BlueTone Media